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Abstract
OBJECTIVE: To explore the effect of kidney-rein-
forcing, blood-activating and stasis-removing reci-
pes on adhesion molecule expression of bone mar-
row mesenchymal stem cells (MSCs) from patients
with chronic aplastic anemia (CAA).
METHODS: We used three Traditional Chinese Med-
icine recipes, namely a kidney-reinforcing recipe
(KRR), blood-activating and stasis-removing recipe
(BASRR), and kidney-reinforcing, blood-activating
and stasis-removing recipe (KRBASRR), and a nor-
mal saline control to prepare herbal medicine se-
rum in Sprague Dawley rats. Thirty CAA patients
were enrolled in the experimental group, including
17 kidney-Yang deficient patients and 13 kidney-Yin
deficient patients. Ten healthy individuals were in-
cluded in the control group. MSCs were isolated
from bone marrow samples, and the cell density
was observed to measure their proliferation ability
by microscopy on days 2, 7, and 14 after isolation.
In addition, the expression of adhesion molecules
of bone marrow MSCs (CD106, CD49d, CD31 and
CD44) were detected by flow cytometry after 48 h
of treatment with the four different herbal medi-
cine serums.
RESULTS: The proliferation of MSCs from kid-
ney-Yang deficient and kidney-Yin deficient pa-
tients was weaker than that of MSCs from the con-
trol group. The expression of all adhesion mole-
cules of bone marrow MSCs from CAA patients was
obviously lower than that in the control group (P<
0.01). The expression of CD49d and CD31 in MSCs
from patients with a kidney-Yin deficiency was low-
er than in those with a kidney-yang deficiency (P<
0.05 and P<0.01, respectively). For kidney-Yang defi-
cient patients, CD31 expression in the KRBASRR
group was significantly higher than that in the
BASRR group (P<0.01), while CD44 in the KRBASRR
group was significantly higher than that in both
KRR and BASRR groups (P<0.01). For kidney-Yin defi-
cient patients, CD106 and CD49d expression in the
KRBASRR group was obviously higher than that in
the KRR group (P<0.05), while CD31 and CD44 ex-
pression in the KRBASRR group was significantly
higher than that in both KRR and BASRR groups (P<
0.05 and P<0.01, respectively).
CONCLUSION: The bone marrow microenviron-
ment in CAA patients is abnormal. The effect of
KRBASRR may be better than that of KRR and
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BASRR for kidney-Yang deficient and kidney-Yin de-
ficient patients by improving the expression levels
of MSC adhesion molecules.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Immunological factors are important for the pathogen-
esis of aplastic anemia (AA). Abnormal cytoimmunity
destroys hematopoietic stem cells (HSCs) and contrib-
utes to suppression of hematopoiesis and pancytope-
nia. Fatty marrow is the most typical pathogenic fea-
ture of AA.1 It is believed that dysimmunity is the main
etiology of acute AA, whereas an abnormal bone mar-
row microenvironment is the most significant etiology
of chronic AA (CAA).2
Bone marrow mesenchymal stem cells (MSCs), a sub-
set of non-HSCs residing in the bone marrow, can dif-
ferentiate into various cell types under certain induc-
tion conditions, including bone marrow stromal cells,
osteoblastic cells, chondroblasts, adipocytes, and mus-
cle cells.3 It has been shown that MSCs have immuno-
suppressive effects on regulating the activity of im-
mune cells through various pathways in both in vivo
and in vitro studies.4 Hematopoietic support of MSCs
and immunosuppression are found to be significantly
reduced in AA patients.5
The "11th Five-Year Plan" AA Group Cooperation of
the State Administration of traditional Chinese medi-
cine (TCM) in China defines "CAA" as "chronic mar-
row fatigue".6 According to Chinese medicine, CAA is
a chronic disease and has a close relationship with the
spleen, kidney and heart. The kidney stores body es-
sences, supports bones and produces marrow. Kidney
deficiency causes a failure to produce marrow and
blood is subsequently unable to be produced, resulting
in blood stasis. On the other hand, patients always suf-
fer from internal heat due to Yin deficiency or toxic
heat entering inwards so that the blood flow becomes
frenetic and bleeding occurs. Localized bleeding causes
further blood stasis. Blood stasis in the bone marrow re-
sults in new blood formation, leading to a poor or dis-
ordered bone marrow hemopoietic function. Qi block
can result in phlegm accumulation and blood stagna-
tion and vice versa, so both of them interact with each
other through formation of Qi block, constituting a
chronic disease.7 As a result, kidney deficiency and
blood stasis are the basic pathogenesis of CAA.
Few studies have been carried out to further character-
ize the mechanism of the damaged inductive hemato-
poietic microenvironment and bone marrow MSC ad-
hesion. This study investigated the expression of MSC
adhesion molecules after treatment of MSCs from
CAA patients with kidney-reinforcing, blood-activat-
ing and stasis-removing recipes.
METHODS
Diagnostic criteria for CAA
Diagnostic Criteria in Modern Medicine (Referring to
the 3rd Edition of Diagnostic and Curative Effect Cri-
teria).9 1) Clinical Manifestations: the disease occurs rel-
atively slowly and symptoms of anemia, infections and
bleeding are relatively mild. 2) Hemogram: the reduc-
tion rate of hemoglobin is relatively slow; reticulocytes,
neutrophils and platelets are in decrease, but not to the
level of acute AA. 3) Bone Marrow Conditions: two to
three categories of myeloid production are in decrease
and there is at least hyperplastic disorder in one area,
such as relatively increased lymphocytes with obviously
decreased megakaryocytes, and increased non-hemato-
poietic cells such as adipocytes in the bone marrow.
Diagnostic criteria in Traditional Chinese Medicine
Diagnostic Criteria in Chinese Medicine (Referring to
the Clinical Pathways of 95 Diseases in 22 Special De-
partments of Traditional Chinese Medicine fomulated
by the State Administration of TCM).6
Main Symptoms: pale facial complexion, palpitations,
shortness of breath, headache and lack of strength.
Yin deficiency pattern: 1) Clinical Manifestations: fe-
verish sensation in the palms, soles and chest, tidal fe-
ver, night sweat, frequent epistaxis, macules in the skin,
thirst, yellow urine, redness of the tongue edges and
tip, thin or scanty tongue coating of fluids. 2) This pat-
tern is more common in kidney-Yin deficiency of CAA.
Yang deficiency pattern: 1) Clinical Manifestations:
cold feeling, cold limbs, bright pale complexion, poor
appetite, loose stool, enlarged tongue bearing tooth
marks, white and slippery tongue coating, deep and
weak pulse. 2) This pattern is more common in kid-
ney-Yang deficiency of CAA.
Patients and healthy donor selection
Thirty cases were recruited from the Hematology De-
partment of our hospital from June 2010 to December
2011, including 18 male cases and 12 female cases, in
which 17 were kidney-Yang deficient and 13 kid-
ney-Yin deficient. The control group consisted of 10
healthy bone marrow MSC donors including five do-
nors of each gender with a median age of 26 (range,
19-38). All patients and healthy donors provided in-
formed consent.
Animals
Eighty Sprague Dawley (SD) male rats of a clean grade
weighing (250±20) g were purchased from the Labora-
tory Animal Center of Zhejiang Chinese Medical Uni-
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versity and cared for in accordance with the policies
and guidelines by Ethic Committee for Animal Use.
All rats were maintained for one week at room tempera-
ture before the experiment, with free access to food
and water. By means of randomized block method, the
80 male SD rats were randomly divided into kidney-re-
inforcing recipe (KRR), blood-activating and stasis-re-
moving recipe (BASRR), kidney-reinforcing, blood-ac-
tivating and stasis-removing recipe (KRBASRR), and
normal saline (control) groups with 20 rats in each
goup. The rats died in a large number of bloodletting.
Chinese medicinals
The Chinese medicinals used in this study were stan-
dard Chinese medicinal granules produced by Tianji-
ang Pharmaceutical Co. Ltd.
Kidney-reinforcing medicinals included Shudihuang
(Radix Rehmanniae Praeparata), Heshouwu (Radix
Polygoni Multiflori), Tusizi (Semen Cuscutae), Buguzhi
(Fructus Psoraleae) andXianlingpi (HerbaEpimedii).
Blood-activating and stasis-removing medicinals includ-
ed Danshen (Radix et Rhizoma Salviae Miltiorrhizae),
Danggui (Radix Angelicae Sinensis), Chishao (Radix
Paeoniae Rubra), Mudanpi (Cortex Moutan) and Hon-
ghua (Flos Carthami).
Kidney-reinforcing, blood-activating and stasis-remov-
ing medicinals included all of the above.
Laboratory apparatus and regents
Laboratory apparatus included a flow cytometer (Bec-
ton-Dickinson, New York, USA), adjustable micropi-
pettes (Eppendorf,Hamburg,Germany), and an inverted
fluorescencemicroscope(Olympus,Shanghai,China).
The reagents were fluorescence-labeled mouse antibod-
ies against human CD31-FITC, CD49d-PE, CD44-
FITC and CD-106-PE, as well as isotype controls (Bio-
Legend, San Diego, USA), Gibco fetal bovine serum
(FBS; Invitrogen, New York, USA), low-glucose Dul-
becco's modified eagle medium (DMEM) containing
penicillin and streptomycin, 0.25% pancreatin and
0.02% ethylene diamine tetra acetic acid (EDTA)
(Hangzhou Genom Biomedical Co., Ltd, Hangzhou,
China), and Human Lymphocyte Separation Medium
(Ficoll; Tianjin Haoyang Biological Manufacture Co.,
Ltd, Tianjin, China).
Medicinal solution
Standard Chinese medicinal granules were prepared in
a water bath to obtain solutions containing 1g/mL-
crude drug. The solutions were stored at 4°C until use.
Preparation of serum with chinese medicinal
ingredients
After living in a barrier system for 4 d, the rats were in-
tragastrically administered the Chinese medicinal solu-
tion (5 mL, twice a day). The medicinal dosage was 20
times more than that for a 50 kg adult. According to
the routine method of preparation of serum with me-
dicinal ingredients, the rats were denied food for 12 h
before blood collection. In the morning of day 4,
blood samples were collected under aseptic conditions
from the abdominal aorta or heart at 1 h after adminis-
tration of the drug solution.
The collected blood was centrifuged (1500 g, 20 min)
to obtain the serum with medicinal ingredients. The
collected serum was mixed, inactivated at 56° C for
30 min and then sterilized by passing through a 0.22 µm
filter. The serum was then stored at -30°C.
Isolation and culture of MSCs
Bone marrow samples (5 mL) were obtained from the
posterior superior iliac spine of patients and healthy do-
nors, and diluted with phosphate buffered saline (PBS)
at the same volume. The diluted bone marrow samples
were layered onto Ficoll at a volume ratio of 1∶2 and
underwent density gradient centrifugation (2500 r/
min, 30 min, upward gradient rate 5 and downward 0)
at 4°C. Mononuclear cells were collected and washed
twice (1200 r/min, 10 min). Then, the mononuclear
cells were counted and suspended in low-glucose
DMEM containing 100 U/mL penicillin (except for
MSCs from allergic patients), 100 U/mL streptomycin
and 10% FBS at a density of 2 × 105 cells/cm2. Cells
were cultured in an incubator at 37°C, 5% CO2 and
saturated humidity. Adherent cells (MSCs) were found
scattered on the culture surface after 48 h of culture
and resembled fibroblasts with the main body in the
clostridial form. Cells reached 90% confluence at an av-
erage of 14 days later. MSCs were ready for use at pas-
sage 3 and the purity was more than 98%.
Co-culture of MSCs and serum containing medicinal
ingredients
MSCs were digested with 0.25% pancreatin and
0.02% EDTA, diluted to a density of 5×104 cells/cm2,
and placed in 6-well plates (1.8 mL in well). Then,
0.2 mL serum containing medicinal ingredients was
added (total volume: 2 mL) for each group. The cells
were then cultured at 37°C and 5% CO2 with saturat-
ed humidity for 48 h.
Flow cytometric analysis
To prepare cells for flow cytometry, MSCs cultured in
the serum containing medicinal ingredients for 48 h
were partly digested with trypsin and washed with PBS
twice (1000 rpm/min, 5 min). Then, the cell density
was adjusted to 1×106 cells/mL and 100 µL of the cell
suspension of each group was incubated with 10 µL
each of CD31-FITC and CD49d-PE, or 10 µl each of
CD44-FITC and CD106-PE. After mixing, cells were
incubated for 20 min at 4° C while protected from
light. The cells were washed and then analyzed by flow
cytometry. Isotype controls were used accordingly.8
Statistical analysis
SPSS 15.0 was used for analysis. Paired t-tests were
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used to compare the means of the same group before
and after treatment. Variance analysis was applied for
normality indexes and pairwise comparison was used.
For non-normality indexes, nonparametric tests were
used, Kruskal-Wallis H tests were applied for multi-
group comparison, and Mann-Whitney U tests were
used for pairwise comparison.
RESULTS
Patient characteristics
Thirty CAA patients were enrolled in this study, in-
cluding 17 kidney-Yang deficient patients (10 males
and seven females) with a mean age of 27 (range, 9-70
years of age), and 13 kidney-Yin deficient patients
(eight males and five females) with a mean age of 23
(range, 9-44 years of age) (Table 1).
Proliferation of MSCs from CAA patients
MSCs were cultured in low-glucose DMEM with 10%
FBS and were similar to fibroblasts with the main body
in the clostridial form after the first medium change at
48 h. Cells reached 90% confluence at an average of
14 days in the shape of radials or swirls. MSCs were
not significantly different in shape between CAA pa-
tients and healthy donors. However, at 48 h, 7 days
and 14 days, the MSC density of CAA patients was
sparser than that of the control group. This observa-
tion indicated that the proliferation ability of MSCs
from both kidney-Yang deficient and kidney-Yin defi-
cient patients was weaker than that of MSCs from
healthy donors (Figures 1-3).
Comparison of MSC adhesion molecule expression
between CAA patients and healthy donors
The expression of adhesion molecules, CD106,
CD49d, CD31 and CD44, in MSCs from CAA pa-
tients, regardless of kidney-Yang or kidney-Yin deficien-
cies, was obviously lower than that in the control
group. The expression of CD31 and CD44 in kid-
ney-Yin deficient patients was lower than that in the
kidney-Yang deficient patients (P<0.01 and <0.05, re-
spectively). There was no significant difference in
CD106 and CD49d expression between kidney-Yin de-
ficient and kidney-Yang deficient patients (Table 2).
Comparison of adhesion molecule expression in
MSCs cultured with different TCM recipes for
kidney-Yang deficient CAA patients
For kidney-Yang deficient patients of the KRR group,
CD49d, CD31 and CD44 expression was significantly
higher than that in the control group (P=0.029, 0.016
and 0.004, respectively). In the BASRR group, CD44
expression was significantly higher than that in the con-
trol group (P<0.01). In the KRBASRR group, expres-
sion of the four MSC adhesion molecules was obvious-
ly higher than that in the control group (P=0.000,
0.001, 0.000 and 0.034, respectively). The expression
of all four molecules showed no significant difference
between KRR and BASRR groups. CD31 expression
in the KRBASRR group was significantly higher than
that in the BASRR group (P<0.01), CD44 expression
in the KRBASRR group was significantly higher than
that in both KRR and BASRR groups (P=0.000 for
both groups) (Figure 4).
Comparison of adhesion molecule expression of
MSCs cultured with different TCM recipes for
kidney-Yin deficient CAA patients
For kidney-Yin deficient patients of the KRR, BASRR
and KRBASRR groups, CD49d, CD31 and CD44 ex-
pression was significantly higher than that in the con-
trol group. In KRR and BASRR groups, the expression
of these four molecules showed no significant differ-
ence (P>0.05). In the KRBASRR group, CD106 and
CD49d expression was not different from that in the
KRR group (P>0.05). CD31 and CD44 expression in
the KRBASRR group was significantly higher than
that in both KRR and BASRR groups (CD31: P=
0.015 and P=0.003, respectively; CD44: P=0.011 and
Group
Kidney-Yang Deficiency
Kidney-Yin Deficiency
n
17
13
Chronic Aplastic Anemia [n (%)]
Male
10 (58.8%)
8 (61.5%)
Female
7 (41.2%)
5 (38.5%)
Mean Age
[Year (range)]
27 (9-70)
23 (9-44)
Table 1 General clinical data of CAA patients
Note: CAA: Chronic aplastic anemia.
Group
Normol Control
Kidney-Yang Deficiency
Kidney-Yin Deficiency
n
10
17
13
CD106
34.1±3.4
2.5±2.4a
1.7±1.4a
CD49d
30.4±1.9
2.2±1.7a
2.6±2.8a
CD31
7.4±1.5
2.3±1.4a
0.5±0.4ab
CD44
98.5±1.3
80.4±4.4a
83.9±4.3ac
Table 2 Comparison of MSC adhesion molecule expression between CAA patients and healthy donors (%, xˉ ±s)
Notes: MSCs: Bone marrow mesenchymal stem cells; CAA: Chronic aplastic anemia; Compared with the normal control group, aP<0.01;
Compared with Kidney-Yang deficiency, bP<0.01, cP<0.05.
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P=0.006, respectively) (Figure 5).
Effects of different TCM recipes on the expression of
MSC adhesion molecules in different TCM patterns
of CAA patients
Expression of MSC adhesion molecules, CD106,
CD49d, CD31 and CD44, increased at varying de-
grees after treatment with KRR, BASRR or
KRBASRR. However, only CD31 expression showed a
significant difference after treatment for different pat-
terns of CAA patients (P<0.01) (Table 3).
DISCUSSION
CAA is a disease that causes hematopoietic failure of
the bone marrow, and the pathogenesis is related to im-
mune hyperfunction, bone marrow stem cell dysfunc-
tion, and hematopoietic inductive microenvironment
disorders.10 Termed as "marrow fatigue" in Chinese
medicine, CAA is clinically defined as a kidney-Yang
deficiency, kidney-Yin deficiency and deficiencies of
both kidney Yin and Yang. KRR is a common clinical
therapy for CAA, but the actual clinical results for
some CAA patients are not desirable and methods that
are more effective need to be further explored.
MSCs are a significant part of the bone marrow im-
mune microenvironment, and are able to establish im-
munosuppressive loci, regulate normal hematopoiesis,
repair the hematopoietic microenvironment and pro-
mote bone marrow hematopoiesis. For AA patients, he-
matopoietic support of MSCs and immunosuppression
are significantly reduced.5 T-cell suppression mediated
by MSCs is deficient in patients with severe AA,11 and
bone marrow MSCs derived from children with severe
AA have poor potentials for proliferation and differenti-
ation.12 However, Xu et al.13 found that the immuno-
suppressive ability of MSCs is not decreased in chil-
dren with AA. Our study found that the proliferation
Figure 1 Bone marrow mesenchymal stem cells from different groups after the first medium change (48 h). (OLYMPUS IX71, illumi-
nation observation 10×10)
A: healthy donors; B: kidney-Yang deficient CAA patients; C: kidney-Yin deficient CAA patients; CAA: chronic aplastic anemia.
A B C
Figure 2 Bone marrowmesenchymal stem cells from different groups after 7 d. (OLYMPUS IX71, illumination observation 10×10)
A: healthy donors; B: kidney-Yang deficient CAA patients; C: kidney-Yin deficient CAA patients; CAA: chronic aplastic anemia.
A B C
Figure 3 Bone marrowmesenchymal stem cells from different groups after 14 d (OLYMPUS IX71, Illumination Observation 10×10)
A: healthy donors; B: kidney-Yang deficient CAA patients; C: kidney-Yin deficient CAA patients; CAA: chronic aplastic anemia.
A B C
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ability of MSCs from CAA patients, regardless of kid-
ney-Yang or kidney-Yin deficiencies, is weaker than
that of MSCs in the normal control group. Thus, a
functional impairment of MSCs exists in CAA patients.
CD106 which is also called vascular cell adhesion mole-
cule-1 (VCAM-1) and its receptor are expressed on
bone marrow stroma cells but rarely on hematopoietic
cells. CD49d is also called very late antigen-4 (VLA-4)
that is expressed mainly on CD34 + cells. These adhe-
sion molecules participate in migration, homing of
HSCs, and formation of HSC-MSC aggregations14 and
play a key role in localization in the bone marrow mi-
croenvironment, and proliferation and differentiation
of HSCs through cell-cell adhesion and signal transmis-
sion.15 CD31 is mainly expressed on the surface of vas-
cular cells and blood cells. It is essential for the differen-
tiation, maturation and release of HSCs into the pe-
ripheral blood from the bone marrow.16 CD44 is a re-
ceptor of lymphocyte homing. It is mainly involved in
cell-cell interactions and cell adhesion for HSC hom-
ing.17 VCAM-1, VLA-4 and CD44 participate in the
homing of HSCs and promote interactions between
HSCs and MSCs, thereby assisting the homing of
HSCs to niches in the bone marrow microenviron-
ment, which are are necessary for growth and develop-
ment of HSCs for hematopoiesis. A previous study
used monoclonal antibodies to block VCAM-1, VLA-4
and CD44 on bone marrow cells and found that 66%,
86%, 77% of HSCs could not home, respectively, and
interactions with MSCs was weakened, indicating the
importance of adhesion molecules in hematopoiesis.18
The expression of CD106, CD44 and CD31 in AA
mice is much lower than that in normal controls.19 Our
study shows that the expression levels of CD106,
CD49d, CD31 and CD44 in MSCs from CAA pa-
tients is obviously lower than those in MSCs from
healthy donors. These results indicate that there is low-
er expression of bone marrow mesenchymal cell adhe-
sion molecules and an impaired bone marrow microen-
vironment in CAA patients, thus weak adhesion and
interactions between HSCs and MSCs may play a role
in the pathogenesis of CAA. Currently, improving the
Figure 4 Comparison of Adhesion Molecule Expression of MSCs cultured with Different TCM Recipes for Kidney-Yang Deficient
CAA Patients
TCM: Traditional Chinese Medicine; MSCs: bone marrow mesenchymal stem cells; CAA: chronic aplastic anemia; Compared with
the control group, aP<0.01, cP<0.05; Compared with the KRR group, dP<0.01; Compared with the BASRR group, bP<0.01.
a ab c c
a
c a
abd
b
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microenvironments of HSCs is the main strategy for
treating AA. However, our study focused on promoting
the expression level of MSC adhesion molecules, which
is different from targeting dysfunctional lymphocytes.
Our previous study20 showed that treating both the
phlegm and blood stasis can affect the apoptosis of nu-
cleated bone marrow cells from AA mice, and the reci-
pe for invigorating the kidney and eliminating phlegm
and stasis can obviously inhibit the apoptosis of bone
marrow hematopoietic cells and thus improve the he-
matopoiesis of bone marrow. In this study, we used ani-
mal serum containing medicinal ingredients of KRR,
Group
KRR
BASRR
KRBASRR
Kidney-Yang Deficiency
Kidney-Yin Deficiency
Kidney-Yang Deficiency
Kidney-Yin Deficiency
Kidney-Yang Deficiency
Kidney-Yin Deficiency
CD106
1.5±1.5
1.6±1.7
1.4±1.7
1.3±1.6
2.5±1.7
2.8±2.5
CD49d
3.1±4.0
1.7±2.0
2.7±4.1
0.8±0.9
4.9±4.6
3.7±3.3
CD31
1.7±1.4
0.4±0.4a
0.9±0.8
0.2±0.4a
3.3±1.9
1.2±0.8a
CD44
3.6±1.6
3.9±2.4
3.8±3.1
3.7±2.9
8.5±3.7
7.2±3.7
Table 3 Expression increases of MSC adhesion molecules at varying degrees after treatment with different TCM recipes in different
patterns of CAA patients (%, xˉ ±s)
Notes: TCM: Traditional Chinese medicine; MSCs: bone marrow mesenchymal stem cells; CAA: chronic aplastic anemia; KRR:
kidney-reinforcing recipe; BASRR: blood-activating and stasis-removing recipe; KRBASRR: kidney-reinforcing, blood-activating and
stasis-removing recipe; Compared with Kidney-Yang deficiency with respect to TCM Recipes, aP<0.01.
Figure 5 Comparison of Adhesion Molecule Expression of MSCs Cultured with Different TCM Recipes for Kidney-yin Deficiency
CAA Patients
TCM: Traditional Chinese Medicine; MSCs: bone marrow mesenchymal stem cells; CAA: chronic aplastic anemia; Compared with
the control group, aP<0.01; Compared with the KRR group, dP<0.01, bP<0.05; Compared with the BASRR group, cP<0.01.
a a abc
a a a
a
aa
ad ab
abc
(
)
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BASRR and KRBASRR to observe the effects on the ex-
pression of bone marrow stromal cell adhesion mole-
cules of CAA patients. MSCs from kidney-Yang defi-
cient or kidney-Yin deficient patients in the KRBASRR
group showed significantly higher expression of MSC
adhesion molecules compared with those in KRR and
BASRR groups (P<0.05 and P<0.01, respectively).
Expression of the four MSC adhesion molecules,
CD106, CD49d, CD31 and CD44, increased at vary-
ing degrees after treatment with KRR, BASRR and
KRBASRR. However, only CD31 expression showed a
significant difference after treatment for different pat-
terns of CAA patients (P<0.01). The results show that
treatment of kidney-Yin deficient patients is more diffi-
cult than that of kidney-Yang deficiency patients.
Our study indicates that the bone marrow MSCs in
CAA patients are characterized by an abnormal quanti-
ty and a deficient proliferation ability. Furthermore,
the expression of bone marrow MSC adhesion mole-
cules is significantly lower than that in healthy individ-
uals. These results validate that the bone marrow micro-
environment in the CAA patients is abnormal, and
that KRBASRR treatment can exert a better effect,
probably by improving the expression levels of MSC
adhesion molecules and the bone marrow hematopoiet-
ic microenvironment. This study also indicates that the
KRBASRR treatment is an efficient therapy for CAA.
However, further research on the specific mechanism is
required to be carried out.
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